e-learning
resources
Berlin 2008
Wednesday, 08.10.2008
Diagnosis and prognosis in thoracic oncology
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Telomerase activity, micrometastasis and lynphonodal metastasis in resected non small cell lung cancer
B. Cattaneo, O. Alabiso, D. Colangelo, S. Della Patrona, P. Tarsia, L. Allegra (Milan, Novara, Italy)
Source:
Annual Congress 2008 - Diagnosis and prognosis in thoracic oncology
Session:
Diagnosis and prognosis in thoracic oncology
Session type:
Oral Presentation
Number:
4399
Disease area:
Thoracic oncology
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
B. Cattaneo, O. Alabiso, D. Colangelo, S. Della Patrona, P. Tarsia, L. Allegra (Milan, Novara, Italy). Telomerase activity, micrometastasis and lynphonodal metastasis in resected non small cell lung cancer. Eur Respir J 2008; 32: Suppl. 52, 4399
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion: ICU admission of lung cancer patients – Is COVID-19 a game-changer?
Surgical vs non-surgical treatment of early stage non-small cell lung cancer: here's the fight
N3 hilar sampling decision in the staging of mediastinal lung cancer
Related content which might interest you:
Determination of distant metastases in non-small cell lung cancer and factors related to presence of metastasis
Source: Annual Congress 2008 - Diagnostic aspects in thoracic oncology
Year: 2008
Large adrenal metastasis in non small cell lung cancer
Source: Eur Respir J 2006; 28: Suppl. 50, 94s
Year: 2006
Correlation between p53 expression in bronchus biopsies from non-small cell lung cancer cases and mediastinal lymph node invasion demonstrated through mediastinoscopy
Source: Eur Respir J 2006; 28: Suppl. 50, 82s
Year: 2006
How to treat a T1-T3N0 non-small cell lung cancer (NSCLC) with isolated brain metastasis
Source: International Congress 2015 – How to treat brain metastases
Year: 2015
An usual metastasis of squamous cell lung cancer: intra-abdominal lymph nodes
Source: Annual Congress 2009 - Clinical aspects and epidemiology in lung cancer
Year: 2009
Telomerase activity as a prognostic marker in non small cell lung cancer
Source: Annual Congress 2008 - Diagnosis and prognosis in thoracic oncology
Year: 2008
Extrathoracic 18-FDG-PET uptakes in non small cell lung cancer (NSCLC) preoperative staging
Source: Eur Respir J 2007; 30: Suppl. 51, 430s
Year: 2007
The affect of the metabolic activity of the primary tumor to lymph node and distant metastasis in non-small cell lung cancer
Source: International Congress 2014 – Improving diagnosis of thoracic tumours
Year: 2014
High-sensitive-detection of VEGF-mRNA in nonsmall-cell lung cancer (NSCLC) metastases of lymphnodes by thyramide amplified
in-situ
hybridization
Source: Eur Respir J 2001; 18: Suppl. 33, 233s
Year: 2001
The correlation of serum tumor markers and distant metastasis in lung adenocarcinoma
Source: International Congress 2017 – Lung cancer - clinical research: scientific pearls from the bedside
Year: 2017
Does expression of betatubulin 3 correlate between primary non small cells lung cancer tumor and metastases?
Source: Annual Congress 2009 - Treatment of lung cancer
Year: 2009
Treatment for non small cell lung cancer presenting with synchronous solitary brain metastases
Source: Annual Congress 2007 - Therapeutic approaches in thoracic oncology
Year: 2007
How to prevent and treat brain metastasis in small cell lung carcinoma
Source: International Congress 2015 – How to treat brain metastases
Year: 2015
Prevalence of silent brain metastasis (BM) in the initial staging of non-small cell lung carcinoma (NSCLC)
Source: Annual Congress 2011 - Imaging, functional evaluation and staging for lung cancer patients
Year: 2011
Prognostic factors in pathological stage IB nonsmall cell lung cancer greater than 3 cm
Source: Eur Respir J 2010; 36: 1355-1361
Year: 2010
Splenic metastasis of lung cancer
Source: Eur Respir J 2006; 28: Suppl. 50, 91s
Year: 2006
Detecting extrathoracic metastases in patients with non-small cell lung cancer
Source: Eur Respir J 2006; 28: Suppl. 50, 41s
Year: 2006
Foxp3+ cells are running the show in patients with surgically resected nonsmall cell lung cancer
Source: Eur Respir J 2015; 46: 1541-1543
Year: 2015
Prognostic factors in resected pathological N1-stage II nonsmall cell lung cancer
Source: Eur Respir J 2013; 41: 649-655
Year: 2013
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept